Literature DB >> 7694488

Primary structures and effects on gastrointestinal motility of tachykinins from the rainbow trout.

J Jensen1, K R Olson, J M Conlon.   

Abstract

Purification and structural characterization of tachykinins from rainbow trout (Oncorhynchus mykiss) intestine has demonstrated the presence of three different peptides related to the mammalian tachykinins: substance P, neurokinin A, and neuropeptide-gamma. The substance P- and the neurokinin A-related peptides present in the intestine are identical to the tachykinins previously isolated from the trout brain. The neuropeptide-gamma-related peptide (Ser-Ser-Ala-Asn-Pro-Gln-Ile-Thr-Arg-Lys-Arg-His-Lys-Ile-Asn-Ser-Phe- Val-Gly-Leu-Met-NH2), not previously identified in brain tissue, has the sequence of the neurokinin A-related tachykinin at its COOH-terminus. Both trout substance P and neurokinin A stimulated the motility of isolated trout intestinal muscle [pD2(-log of EC50) values 8.5 +/- 0.15 and 7.35 +/- 0.08, respectively] and the vascularly perfused trout stomach (pD2 values 9.63 +/- 0.23 and 8.18 +/- 0.23, respectively). Trout substance P was 14 times more potent than trout neurokinin A in the intestine and 28 times more potent in the stomach. The data suggest that receptors interacting with tachykinins in the trout gastrointestinal tract have a similar selectivity as the mammalian NK-1 receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694488     DOI: 10.1152/ajpregu.1993.265.4.R804

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Effects of substance P and distribution of substance P-like immunoreactivity in nerves supplying the stomach of the cod, Gadus morhua.

Authors:  J Jensen; P Karila; A C Jönsson; G Aldman; S Holmgren
Journal:  Fish Physiol Biochem       Date:  1993-10       Impact factor: 2.794

2.  Brain neuropeptides in central ventilatory and cardiovascular regulation in trout.

Authors:  Jean-Claude Le Mével; Frédéric Lancien; Nagi Mimassi; J Michael Conlon
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-30       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.